Byotrol plc Stock

Equities

BYOT

GB00B0999995

Personal Products

Delayed London S.E. 09:44:50 2024-04-24 am EDT 5-day change 1st Jan Change
0.0755 GBX -39.60% Intraday chart for Byotrol plc -24.50% -89.21%
Sales 2024 * 4.7M 5.85M Sales 2025 * - Capitalization 567K 706K
Net income 2024 * - 0 Net income 2025 * - EV / Sales 2024 * 0.27 x
Net Debt 2024 * 705K 877K Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-0.63 x
P/E ratio 2025 *
-
Employees 36
Yield 2024 *
-
Yield 2025 *
-
Free-Float 40.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day-39.60%
1 week-24.50%
Current month-49.67%
1 month-81.12%
3 months-89.59%
6 months-93.43%
Current year-89.21%
More quotes
1 week
0.05
Extreme 0.0501
0.15
1 month
0.05
Extreme 0.0501
0.45
Current year
0.05
Extreme 0.0501
0.84
1 year
0.05
Extreme 0.0501
2.60
3 years
0.05
Extreme 0.0501
7.70
5 years
0.05
Extreme 0.0501
10.10
10 years
0.05
Extreme 0.0501
10.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 13-10-08
Director of Finance/CFO 48 21-12-12
Chairman 73 14-11-24
Members of the board TitleAgeSince
Director/Board Member 73 23-09-12
Director/Board Member - 19-01-28
Chief Executive Officer 59 13-10-08
More insiders
Date Price Change Volume
24-04-24 0.0755 -39.60% 4 085 813
24-04-23 0.125 +25.00% 4,862,736
24-04-22 0.1 0.00% 3,799,480
24-04-19 0.1 -20.00% 7,964,210
24-04-18 0.125 +25.00% 16,940,100

Delayed Quote London S.E., April 24, 2024 at 09:44 am EDT

More quotes
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
More about the company

Annual profits - Rate of surprise